Literature DB >> 28882856

Contemporary Management of Hepatitis C in Patients with CKD.

Richard J Johnson1, Michiko Shimada2.   

Abstract

Entities:  

Keywords:  Disease Management; Hepacivirus; Hepatitis C; Humans; Renal Insufficiency, Chronic

Mesh：

Year:  2017        PMID： 28882856      PMCID： PMC5628720          DOI： 10.2215/CJN.07620717

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  15 in total

1.  Rituximab plus Peg-interferon-alpha/ribavirin compared with Peg-interferon-alpha/ribavirin in hepatitis C-related mixed cryoglobulinemia.

Authors:  David Saadoun; Mathieu Resche Rigon; Damien Sene; Benjamin Terrier; Alexandre Karras; Laurent Perard; Yoland Schoindre; Brigitte Coppéré; François Blanc; Lucile Musset; Jean-Charles Piette; Michele Rosenzwajg; Patrice Cacoub
Journal:  Blood       Date:  2010-05-03       Impact factor: 22.113

Review 2.  Hepatitis C Virus Infection Increases the Risk of Developing Chronic Kidney Disease: A Systematic Review and Meta-Analysis.

Authors:  Fabrizio Fabrizi; Simona Verdesca; Piergiorgio Messa; Paul Martin
Journal:  Dig Dis Sci       Date:  2015-07-21       Impact factor: 3.199

3.  Efficacy of Direct-Acting Antiviral Combination for Patients With Hepatitis C Virus Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal Disease.

Authors:  Paul J Pockros; K Rajender Reddy; Parvez S Mantry; Eric Cohen; Michael Bennett; Mark S Sulkowski; David E Bernstein; Daniel E Cohen; Nancy S Shulman; Deli Wang; Amit Khatri; Manal Abunimeh; Thomas Podsadecki; Eric Lawitz
Journal:  Gastroenterology       Date:  2016-03-11       Impact factor: 22.682

4.  Use of sofosbuvir-based direct-acting antiviral therapy for hepatitis C viral infection in patients with severe renal insufficiency.

Authors:  Gregory L Hundemer; Meghan E Sise; Jessica Wisocky; Nneka Ufere; Lawrence S Friedman; Kathleen E Corey; Raymond T Chung
Journal:  Infect Dis (Lond)       Date:  2015-08-18

Review 5.  Ledipasvir-Sofosbuvir: A Once-Daily Oral Treatment Option for Chronic Hepatitis C Virus Genotype 1 Infection.

Authors:  Christopher M Jensen; Lisa M Holle
Journal:  Pharmacotherapy       Date:  2016-05-12       Impact factor: 4.705

6.  Effect of Sofosbuvir-Based Hepatitis C Virus Therapy on Kidney Function in Patients with CKD.

Authors:  Meghan E Sise; Elke Backman; Guillermo A Ortiz; Gregory L Hundemer; Nneka N Ufere; Donald F Chute; Joseph Brancale; Dihua Xu; Jessica Wisocky; Ming V Lin; Arthur Y Kim; Ravi Thadhani; Raymond T Chung
Journal:  Clin J Am Soc Nephrol       Date:  2017-09-07       Impact factor: 8.237

7.  Membranoproliferative glomerulonephritis associated with hepatitis C virus infection.

Authors:  R J Johnson; D R Gretch; H Yamabe; J Hart; C E Bacchi; P Hartwell; W G Couser; L Corey; M H Wener; C E Alpers
Journal:  N Engl J Med       Date:  1993-02-18       Impact factor: 91.245

8.  Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study.

Authors:  Eric Lawitz; Mark S Sulkowski; Reem Ghalib; Maribel Rodriguez-Torres; Zobair M Younossi; Ana Corregidor; Edwin DeJesus; Brian Pearlman; Mordechai Rabinovitz; Norman Gitlin; Joseph K Lim; Paul J Pockros; John D Scott; Bart Fevery; Tom Lambrecht; Sivi Ouwerkerk-Mahadevan; Katleen Callewaert; William T Symonds; Gaston Picchio; Karen L Lindsay; Maria Beumont; Ira M Jacobson
Journal:  Lancet       Date:  2014-07-28       Impact factor: 79.321

Review 9.  New insights into HCV-related rheumatologic disorders: A review.

Authors:  Patrice Cacoub; Cloé Comarmond
Journal:  J Adv Res       Date:  2016-07-25       Impact factor: 10.479

Review 10.  Daclatasvir/asunaprevir based direct-acting antiviral therapy ameliorate hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis: a case report.

Authors:  Michiko Shimada; Norio Nakamura; Tetsu Endo; Hideaki Yamabe; Masayuki Nakamura; Reiichi Murakami; Ikuyo Narita; Hirofumi Tomita
Journal:  BMC Nephrol       Date:  2017-03-29       Impact factor: 2.388
View more
  1 in total

1.  Liver Iron Load Influences Hepatic Fat Fraction in End-Stage Renal Disease Patients on Dialysis: A Proof of Concept Study.

Authors:  Guy Rostoker; Christelle Loridon; Mireille Griuncelli; Clémentine Rabaté; Fanny Lepeytre; Pablo Ureña-Torres; Belkacem Issad; Nasredine Ghali; Yves Cohen
Journal:  EBioMedicine       Date:  2018-11-28       Impact factor: 8.143
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.